ELUT Q4 2022 Earnings — Elutia Inc. Revenue & Financial Results | Market Cap Arena

ELUTElutia Inc.

$48M

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$13M+16.6% YoY

Gross Profit

$5M39.4% margin

Operating Income

-$9M-69.8% margin

Net Income

-$5M-43.0% margin

EPS (Diluted)

$-0.38

QoQ Revenue Growth

+116.5%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$774,000

Balance Sheet

Total Assets

$69M

Total Liabilities

$74M

Stockholders' Equity

-$5M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$13M	$11M	+16.6%
Gross Profit	$5M	$3M	+47.3%
Operating Income	-$9M	-$8M	-13.9%
Net Income	-$5M	-$9M	+40.0%